Clinical trial

Augmenting Cerebral Blood Flow to Treat Established Multiple Sclerosis

NCT02466074

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2016-08-17

PhasePHASE2

Study timeline

Study start (actual)2016-08-17Date precision: day

Registry last updated2023-04-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

AcetazolamideDRUG · verified · RxNorm: acetazolamide

PlaceboDRUG

Sponsors & collaborators

The University of Texas Health Science Center, Houstonlead sponsor

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02466074 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.